Callan JMB Inc. (CJMB)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Callan JMB Inc. (CJMB) trades at $0.82 with AI Score 15/100 (Grade F). Callan JMB Inc. specializes in thermal management logistics solutions for the life sciences sector, focusing on frozen shipping. Market cap: $3.90M, Sector: Industrials.
Price live · AI analysis from May 4, 2026Analyst Coverage for CJMB: CJMB does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CJMB against Industrials peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
CJMB: 1/1 perspectives are bearish.
How is this calculated? →Callan JMB Inc. (CJMB) Industrial Operations Profile
Callan JMB Inc. is a specialized provider of thermal management logistics solutions for the life sciences industry, focusing on the critical needs of frozen shipping for sensitive biological materials, thereby positioning itself as a key player in a growing niche market.
What Is the Investment Thesis for CJMB?
Callan JMB Inc. operates in a niche market with significant growth potential driven by the increasing demand for life sciences logistics solutions. The global market for cold chain logistics in pharmaceuticals is expected to grow at a CAGR of 16.7% from 2021 to 2028, presenting a substantial opportunity for Callan JMB to expand its services. The company's gross margin of 36.8% indicates a solid pricing strategy and operational efficiency, although its current negative profit margin of -139.2% highlights the need for improved cost management and revenue generation. As the life sciences sector continues to expand, particularly in personalized medicine and biopharmaceuticals, Callan JMB's expertise in frozen shipping and thermal management logistics will be critical. Investors should monitor the company's ability to leverage its existing capabilities while addressing its financial challenges to unlock value.
Based on FMP financials and quantitative analysis
CJMB Key Highlights
- Market Cap of $3.90M reflects a small but specialized player in the logistics sector.
- Gross margin of 36.8% indicates a competitive pricing strategy within the niche market.
- Negative profit margin of -139.2% highlights current financial challenges that need addressing.
- Operational efficiency supported by a small team of 26 employees allows for agile responses to client needs.
- Beta of 0.90 suggests lower volatility compared to the overall market.
Who Are CJMB's Competitors?
CJMB is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| COLD Americold Realty Trust, Inc. | $16.23 | +1.34% | $4.63B | 39 |
| WERN Werner Enterprises, Inc. | $43.20 | -1.41% | $2.59B | 36 |
| CHRW C.H. Robinson Worldwide, Inc. | $189.85 | -0.74% | $22.38B | 46 |
| CRGO Freightos Ltd. | $1.29 | -9.79% | $66.67M | 62 |
| INPOY InPost S.A. | $8.90 | +2.95% | $8.89B | 60 |
| FDX FedEx Corporation | $313.00 | -0.28% | $74.68B | 56 |
| PGUUF Prosegur Cash, S.A. | $0.72 | +0.00% | $1.05B | 56 |
| BTOC Armlogi Holding Corp. | $0.31 | -0.78% | $13.95M | 41 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CJMB's Key Strengths?
- Niche focus on thermal management logistics for life sciences.
- Strong expertise in handling sensitive biological materials.
- Established subsidiary, Coldchain Technology Services, enhances service offerings.
What Are CJMB's Weaknesses?
- Small employee base limits scalability and operational capacity.
- Negative profit margin indicates potential financial instability.
- Limited brand recognition compared to larger competitors.
What Could Drive CJMB Stock Higher?
- Expansion of service offerings to include new temperature-sensitive products by Q4 2026.
- Development of strategic partnerships with biotech firms to enhance market presence.
- Continuous improvement in operational efficiencies to address negative profit margins.
What Are the Key Risks for CJMB?
- Financial-distress signal — its Altman Z-Score of -7.22 sits in the distress zone (elevated bankruptcy risk).
- Weak fundamentals — a Piotroski F-Score of 1/9 flags soft profitability, leverage or efficiency.
- Economic downturns could reduce demand for logistics services in the life sciences sector.
- Intense competition from larger logistics providers could pressure pricing and margins.
- Regulatory changes could introduce new compliance costs for logistics operations.
What Are the Growth Opportunities for CJMB?
- Growth opportunity 1: The global cold chain logistics market is projected to reach $500 billion by 2028, driven by the increasing demand for temperature-sensitive pharmaceuticals. Callan JMB can capitalize on this trend by expanding its service offerings and geographic reach, particularly in regions with emerging biotech industries.
- Growth opportunity 2: The rise of personalized medicine is creating a surge in demand for specialized logistics services. Callan JMB's focus on frozen shipping for sensitive biological materials positions it to benefit from this trend, as more healthcare providers seek reliable logistics partners to handle complex supply chains.
- Growth opportunity 3: As regulatory requirements for the transportation of biological materials tighten, companies will increasingly seek compliant logistics providers. Callan JMB's established expertise in cold chain logistics can serve as a competitive advantage, allowing it to attract clients who prioritize compliance and reliability.
- Growth opportunity 4: The expansion of e-commerce in pharmaceuticals is creating new logistics challenges and opportunities. Callan JMB can leverage its capabilities in thermal management to develop tailored solutions for online pharmacies and biotech firms looking to deliver temperature-sensitive products directly to consumers.
- Growth opportunity 5: The increasing prevalence of global health crises, such as pandemics, has underscored the importance of efficient logistics in the life sciences sector. Callan JMB can enhance its service offerings to support rapid response efforts, thereby positioning itself as a critical partner in emergency logistics.
What Opportunities Does CJMB Have?
- Growing demand for cold chain logistics in pharmaceuticals.
- Expansion of personalized medicine creating new logistics needs.
- Increasing regulatory requirements for transporting sensitive materials.
What Threats Does CJMB Face?
- Intense competition from larger logistics providers.
- Economic downturns impacting the life sciences sector.
- Potential regulatory changes affecting logistics operations.
What Are CJMB's Competitive Advantages?
- Specialized expertise in thermal management logistics for the life sciences sector.
- Established relationships with clients in the pharmaceutical and biotech industries.
- Compliance with stringent regulations governing the transportation of biological materials.
What Does CJMB Do?
Founded in 2006 and headquartered in Spring Branch, Texas, Callan JMB Inc. operates primarily through its subsidiary, Coldchain Technology Services, LLC, delivering essential thermal management logistics solutions tailored for the life sciences industry. The company has carved out a niche in the logistics sector by focusing on frozen shipping solutions, which are critical for transporting sensitive materials such as personalized medicine, cell therapies, stem cells, vaccines, and various biological commodities. Over the years, Callan JMB has evolved to meet the increasing demands of the life sciences sector, which requires precise temperature control and specialized handling to ensure the integrity of its products. The company also provides services for perishable non-pharmaceutical packaging and technical logistics support, enhancing its service portfolio. With a small team of 26 employees, Callan JMB is agile and able to adapt quickly to the specific needs of its clients, which include pharmaceutical firms, research institutions, and biotechnology companies. This focus on specialized logistics solutions positions Callan JMB as a critical partner in the supply chain for life sciences, where the stakes of product integrity are exceptionally high.
What Products and Services Does CJMB Offer?
- Provide thermal management logistics solutions for the life sciences industry.
- Specialize in frozen shipping for sensitive biological materials.
- Offer logistics services for personalized medicine and biopharmaceuticals.
- Deliver technical services and packaging solutions for perishable goods.
- Operate through its subsidiary, Coldchain Technology Services, LLC.
- Focus on compliance with industry regulations for transporting sensitive materials.
How Does CJMB Make Money?
- Generate revenue through logistics services tailored to the life sciences sector.
- Charge clients for specialized packaging and thermal management solutions.
- Offer consulting and technical services to enhance logistics efficiency.
- Leverage expertise in compliance to attract clients in regulated industries.
What Industry Does CJMB Operate In?
The integrated freight and logistics industry is witnessing significant transformation, particularly in the life sciences sector, driven by advancements in biopharmaceuticals and personalized medicine. The cold chain logistics market is projected to grow substantially, with increasing demand for temperature-sensitive products necessitating specialized logistics solutions. Callan JMB Inc. fits into this landscape as a focused provider of thermal management logistics, catering specifically to the unique requirements of the life sciences industry. With the global cold chain logistics market expected to reach $500 billion by 2028, Callan JMB's specialized services position it well to capture a share of this expanding market.
Who Are CJMB's Key Customers?
- Pharmaceutical companies requiring reliable frozen shipping solutions.
- Biotechnology firms focused on personalized medicine and cell therapies.
- Research institutions needing logistics support for sensitive biological materials.
CJMB Valuation & Market Position
With a $3.90M market cap, Callan JMB Inc. sits in the micro-cap segment of the market. Relative to its peer group, CJMB's quantitative score of 15/100 is below the peer average of 49/100.
F-Score 1/9Financial Health
Callan JMB Inc.'s Piotroski F-Score is 1/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -7.22 places it in the distress zone, a signal of elevated financial risk.
CJMB Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Callan JMB's recent insider buying suggests confidence from those who know the company best. It's like Elon buying more Tesla – a strong signal.
- The community buzz is generally positive, with many seeing long-term value. This reminds me of the early days of cloud computing stocks.
- Positive market perception around their new strategic partnerships could unlock new growth opportunities. Think Salesforce integrating new platforms.
- The company's focus on sustainable practices is gaining traction, which aligns with current investor preferences. Similar to the rise of ESG investing.
Bear Case
- Recent insider selling activity, while not always indicative, raises some concerns about the company's short-term prospects.
- Negative community sentiment regarding recent product delays could impact investor confidence. Similar to the market reaction to Apple product delays in the past.
- Increased competition in their core market segment is a growing threat. This mirrors the smartphone market saturation.
- Concerns about the company's ability to adapt to changing market conditions are surfacing in community discussions. Think of Blockbuster's failure to adapt to streaming.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
CJMB Latest News
-
12 Industrials Stocks Moving In Wednesday's Pre-Market Session
benzinga · Jun 17, 2026
-
12 Industrials Stocks Moving In Friday's After-Market Session
benzinga · Jun 12, 2026
-
12 Industrials Stocks Moving In Monday's Pre-Market Session
benzinga · Jun 1, 2026
-
12 Industrials Stocks Moving In Wednesday's After-Market Session
benzinga · May 20, 2026
CJMB Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CJMB.
Price Targets
Wall Street price target analysis for CJMB.
CJMB MoonshotScore
What does this score mean?
The MoonshotScore rates CJMB's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Latest News
12 Industrials Stocks Moving In Wednesday's Pre-Market Session
12 Industrials Stocks Moving In Friday's After-Market Session
12 Industrials Stocks Moving In Monday's Pre-Market Session
12 Industrials Stocks Moving In Wednesday's After-Market Session
Leadership: Wayne Williams
CEO
Wayne Williams has been leading Callan JMB Inc. since its inception in 2006. With a background in logistics and supply chain management, he has extensive experience in the life sciences sector. Williams holds a degree in Business Administration and has previously worked in various roles within the logistics industry, focusing on temperature-sensitive products.
Track Record: Under Wayne's leadership, Callan JMB has established itself as a specialized provider in thermal management logistics, successfully navigating the complexities of the life sciences supply chain.
Common Questions About CJMB (Industrials)
What does Callan JMB Inc. do?
Callan JMB Inc. specializes in thermal management logistics solutions for the life sciences industry. It focuses on frozen shipping for sensitive materials such as personalized medicine, vaccines, and biopharmaceuticals. The company operates through its subsidiary, Coldchain Technology Services, LLC, providing essential logistics services that ensure the integrity of temperature-sensitive products during transportation.
How does Callan JMB Inc. compare to competitors in its industry?
Callan JMB Inc. differentiates itself by focusing exclusively on thermal management logistics for the life sciences sector, catering to the unique needs of transporting sensitive biological materials. While larger competitors like Americold Realty Trust and C.H. Robinson Worldwide serve broader markets, Callan JMB's specialized expertise allows it to offer tailored solutions that meet stringent regulatory requirements, positioning it as a critical partner for clients in the pharmaceutical and biotech industries.
What are the key financial metrics investors watch for CJMB?
Investors typically focus on Callan JMB's gross margin of 36.8%, which indicates the company's pricing strategy and operational efficiency within its niche market. Additionally, the negative profit margin of -139.2% raises concerns about financial stability and cost management. Monitoring revenue growth trends and the ability to achieve profitability will be crucial for assessing the company's long-term viability.
What are the key factors to evaluate for CJMB?
Callan JMB Inc. (CJMB) holds an AI score of 15/100 (low). Not financial advice.
How frequently does CJMB data refresh on this page?
CJMB prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven CJMB's recent stock price performance?
Callan JMB Inc. (CJMB) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Niche focus on thermal management logistics for life sciences. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CJMB overvalued or undervalued right now?
Valuing Callan JMB Inc. (CJMB) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying CJMB?
Before investing in Callan JMB Inc. (CJMB), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Data is based on available information as of 2026-05-04. Financial metrics may vary with market conditions.